SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)

Clinical trial NCT07021794 · RECRUITING

Trial details

NCT number: NCT07021794
Sponsor: Nancy Klimas
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Post-COVID / Long-COVID

Start date: 2025-06-16
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.